- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
GPAT 2024: NBE issues corrigendum On Information Bulletin, Details
New Delhi- Through a recent notice, the National Board of Examination (NBE) has issued a corrigendum in the information bulletin for the Graduate Pharmacy Aptitude Test (GPAT) 2024.
The National Board of Examination in Medical Sciences (NBMES) is going to conduct the Graduate Pharmacy Aptitude Test (GPAT) for the 2024 session on June 8, 2024, on a computer-based platform at various testing centres across the country. On this, NBE had released an information bulletin detailing the eligibility criteria, fee structure and scheme of examination. However now, the NBE has made amendments to 2 of the clauses mentioned in the information bulletin.
As per the notice, the below-mentioned clauses in the mentioned in the information bulletin have been amended and should be read as under:
S.NO | CLAUSES | PARA NOTIFIED | PARA SHALL BE READ AS |
1 | 2.14 (Page No.16). | Candidates should ensure before applying for the examination that their B. Pharma degree is recognised as per provisions of the Section 12 of the Pharmacy Act, 1948. If it is found at any time that a B. Pharma degree is not recognised, the candidature/result of the candidate shall be cancelled/ deemed to be cancelled. | Candidates should ensure before applying for the examination that their B. Pharma degree is recognised as per provisions of the Section 12 of the Pharmacy Act, 1948 and Conduct of Course. If it is found at any time that a B. Pharma degree is not recognised, the candidature/result of the candidate shall be cancelled/ deemed to be cancelled. |
2 | 5.2 (Page No. 27). | The syllabus for the GPAT shall comprise of subject/knowledge areas as per “The Bachelor of Pharmacy (B. Pharm.) Course Regulations, 2024”. | The syllabus for the GPAT shall comprise of subject/knowledge areas as per “The Bachelor of Pharmacy (B. Pharm.) Course Regulations, 2014”. |
To view the notice, click the link below
However, the rest of the terms and conditions in the Information Bulletin for GPAT 2024 remain unchanged.
For queries related to eligibility/documents/images, candidates may write to the official communication web portal of NBEMS mentioned in the notice.
Meanwhile, the registration process for the GPAT 2024 exam is ongoing and will end today by 11:55 PM. The application can only be submitted online at the NBE official website. Medical Dialogues had earlier reported on the registration process, eligibility criteria, schedule, fee, and exam scheme of the GPAT 2024 exam.
IMPORTANT DATES
S.NO | PROCESSES | TIMELINES |
1 | Online Submission of Applications | 19th April 2024 (3 PM Onwards) to 8th May 2024 (Till 11:55 PM) |
2 | Edit Window for All Payment Success Applications (Any information/documents can be edited except Name, Nationality, Email, Mobile number and Test City). | 11th May 2024 to 14th May 2024 |
3 | Final and Selective Edit Window to rectify Deficient/Incorrect Images (No further opportunity shall be given)- 1 Photograph. 2 Signatures. 3 Thumb Impression. | Pre-Final Edit Window: 21st May to 23rd May 2024 Final Edit Window: 28th May to 30th May 2024 |
4 | Issue of Admit Card. | 3rd June 2024 |
5 | Examination Date | 8th June 2024 |
6 | Declaration of Result | By 8th July 2024 |
EXAMINATION FEE
S.NO | CATEGORY OF CANDIDATES | EXAMINATION FEE |
1 | General, OBC and EWS | Rs. 3500/- |
2 | SC, ST, PWD | Rs. 2500/- |
The application form once submitted cannot be withdrawn as well as the fee can neither be carried forward to a future date nor refunded under any circumstances. Any claim for refund, adjustment or carrying forward of the Application fee will not be entertained.
1 The candidate should be a citizen of India.
2 The candidate must hold a Bachelor’s degree in Pharmacy (4 years after 10+2, including lateral entry students) or equivalent from a recognised university.
3 Candidates appearing for the final year (4th Year) examination of Bachelor of Pharmacy (B. Pharm) whose results will be declared before commencement of admission to the M. Pharm course for the academic year 2024-25 are eligible to appear in GPAT 2024. Candidates appearing for the Prefinal year (3rd Year) examination of Bachelor of Pharmacy (B. Pharm) whose results for the Final Year (4th Year) will be declared before commencement of admission to the M. Pharm course for the academic year 2025-26 are also eligible to appear in GPAT 2024.
4 B.E./ B.Tech. (Pharmaceutical and Fine Chemical Technology)/ equivalent candidates are not eligible to appear in GPAT 2024.
5 Candidates found to be ineligible at any stage of GPAT 2024 will not be permitted to appear in the examination and/or counselling. In the unlikely event of any ineligible candidate appearing and/or being successful in the GPAT 2024, the results/ candidature of such candidate shall be cancelled and/or will be deemed to be cancelled.
6 Eligibility of candidates issued admit card for the examination shall be purely provisional. Appearance in GPAT 2024 does not confer any automatic rights upon the candidate for admission to M. Pharm courses and/or award of scholarship.
7 Candidates are advised not to canvass with NBEMS for eligibility in GPAT or issuance of admit card. Queries, if any, can be submitted through the Communication Web Portal only. Canvassing in any form shall invite rejection of the application.
SCHEME OF GPAT 2024
SYLLABUS
The syllabus for the GPAT shall comprise the subject/knowledge areas as per “The Bachelor of Pharmacy (B. Pharm.) Course Regulations, 2024”.
The examination shall be a multiple choice questions test delivered using a computer network (CBT) as per the scheme prescribed. An indicative Blueprint of the examination is as under:
S.NO | TYPE OF QUESTIONS | No. OF QUESTIONS | MAXIMUM MARKS |
1 | Pharmaceutical Chemistry & Allied Subjects | 38 | 152 |
2 | Pharmaceutics & Allied Subjects | 38 | 152 |
3 | Pharmacognosy & Allied Subjects | 10 | 40 |
4 | Pharmacology & Allied Subjects | 28 | 112 |
5 | Other Subjects of B. Pharm course | 11 | 44 |
TOTAL | 125 | 500 |
The exam comprises of 125 Multiple Choice Questions with each question having 4 response options/ distractors in the English language only. Candidates are required to select the correct/best/most appropriate response/answer out of the 4 response options provided in each question. The time allotted is 3 hrs (180 minutes).
MARKING SCHEME
S.NO | RESPONSE | MARKS |
1 | Correct Response | 4 Marks |
2 | Incorrect Response | 1 Mark shall be deducted |
3 | Unattempted Question | Zero |
1 There shall be a 25% negative marking for incorrect answers. No marks will be deducted for unattempted questions.
2 The question paper for GAPT will be divided into multiple time-bound sections. For example, if there are 5-time bound sections* (Section A, B, C, D & E) in the question paper, each Section will have 25 questions and 36 minutes allotted for the section. Candidates would be restricted to proceed to the next section only after completion of the allotted time of the previous section and candidates would not be allowed to review the questions/modify the responses of a section after the completion of the allotted time of that section. Questions of the next section will start automatically after the completion of the allotted time of the previous section.
3 Candidates will be given the option to mark any question, whether attempted or not, for review which means that the candidate has been given an option to go through these questions in a section again before the allotted time to a section ends. Candidates may note that such questions which are marked for review shall be evaluated as per the marking scheme mentioned above.
S.NO | ACTIVITIES | TIME |
1 | Allow Candidates to enter the examination centre and Commence Registration for the test | 12:00 PM |
2 | Entry closes at the Examination Center | 01:30 PM |
3 | Grant access for Candidate Login | 01:45 PM |
4 | Candidates log in to read instructions | 01:50 PM |
5 | Exam Start Time | 02:00 PM |
6 | Exam End Time | 05:00 PM |
STEPS FOR A COMPUTER-BASED TEST
Submit Online Application Form
⬇️
Edit Application in Edit Window, if required
⬇️
Rectify Images in the Final Edit Window, if asked
⬇️
Watch Demo Test (At NBEMS Website)
⬇️
Download Admit Card
⬇️
Report at Test Centre on Schedule Date &Time
⬇️
Security Check-in Process
⬇️
Registration for Test + Face ID & Biometric Capture
⬇️
Examination Begins
⬇️
During Exam FaceID/Biometric Verification
⬇️
Examination Ends
I am a student of Journalism and Mass Communication and also a passionate writer and explorer. With a keen interest in medicine, I have joined Medical Dialogues as a Content Writer. Within this role, I curate various healthcare-related news including the latest updates on health, hospitals, and regulatory updates from NMC/DCI. For any query or information, feel free to reach out to me at editorial@medicaldialogues.in